Skip to main content
. 2014 May 20;48(12):7018–7025. doi: 10.1021/es502076j

Table 4. Percent Change (95% Confidence Interval)a in Urinary Oxidative Stress Biomarker in Association with Interquartile Range Increase in Urinary Phthalate Metabolite Concentration.

  OHdG
Isoprostane
  %Δ (95% CI) p %Δ (95% CI) p
MEHP 17.7 (2.35, 35.3) 0.03 34.9 (15.9, 57.1) <0.01
MEHHP 14.5 (0.73, 30.2) 0.04 30.2 (13.5, 49.3) <0.01
MEOHP 17.9 (3.00, 34.9) 0.02 34.3 (16.4, 55.0) <0.01
MECPP 15.1 (0.34, 32.1) 0.05 28.4 (10.9, 48.7) <0.01
MCPP 2.31 (−9.31, 15.4) 0.71 23.7 (9.04, 40.4) <0.01
MCOP 3.18 (−8.22, 16.0) 0.60 24.2 (8.94, 41.6) <0.01
MCNP 7.72 (−2.62, 19.2) 0.15 18.9 (6.94, 32.2) <0.01
MBzP 13.3 (−3.35, 32.8) 0.13 35.3 (14.5, 59.9) <0.01
MBP 23.9 (9.37, 40.4) <0.01 49.7 (32.0, 69.8) <0.01
MiBP 19.9 (5.52, 36.2) 0.01 48.8 (30.4, 69.8) <0.01
MEP 11.4 (−5.50, 31.3) 0.20 19.4 (−1.56, 44.8) 0.08
a

Estimates created from linear mixed models with random slopes for subject ID and adjustment for urinary specific gravity, visit of sample collection, and maternal prepregnancy BMI, education, and income level. N = 46 subjects; N = 125 observations.